![]() CleanMyMac X allows you to remove Intel binaries if you are running a computer with Apple Silicon in order to save precious hard drive space. Rosetta 2 technology allows developers to ship a single version of their app containing the Apple Silicon and Intel code. Today’s update to CleanMyMac X brings it more inline with Big Sur with a new icon, refreshed colors, simpler shapes of UI elements, and few a subtle 3D Parallax animations. MacOS Big Sur brought on one of the biggest changes to the Mac user interface in many years, so most apps have some work to do in order to “fit in” better with the new design. ![]() MacPaw has made some important changes to get the app running even faster for those using one of the new MacBook Airs, MacBook Pros, or Mac minis. Apple Silicon SupportĪlthough it ran great under Big Sur using Rosetta 2, CleanMyMac X is now optimized for Apple’s new M1 chip using Apple Silicon technology. Today, they’ve released a great update that adds support for Apple Silicon, a refreshed interface for macOS Big Sur, and the option to remove Intel binaries. The remainder of CDC’s risk assessment remains unchanged from last week’s (August 30 th) update.CleanMyMac X is one of my favorite Mac utilities for uninstalling apps I no longer needed, freeing up hard drive space by clearing full caches and general macOS maintenance. Additional studies on this are ongoing, and we expect to learn more in upcoming weeks. Real-world data are needed to fully understand the impact given the complexities of the immune response to this variant. Additionally, based on CDC’s experience with past SARS-CoV-2 variants, people will likely have protection against severe disease mediated by both cellular and antibody immunity. Preliminary data from laboratory-studies from multiple investigators suggest similar antibody activity against BA.2.86 as compared to other currently circulating viruses.ĬDC and other experts are reassured by these research findings that support the effectiveness of this type of immunity against this variant. Recent Scientific Findings on the Immunology of BA.2.86īecause of the sequence divergence of BA.2.86, there was initial concern of a significant reduction in antibody activity. SARS-CoV-2 Interagency Group (SIG) classified BA.2.86 as a Variant being Monitored (VBM) on September 1, 2023. The variant has also been identified in wastewater samples in two states, New York and Ohio. ![]() states as of September 8, 2023, at 11:30 AM EDT- in people across Colorado, Delaware, Michigan, Ohio, Pennsylvania, Virginia, and Washington, as well as one additional human case that is being investigated. The variant has been identified in nine U.S. Since CDC’s initial risk assessment, BA.2.86 has been identified in additional countries from both human and wastewater specimens.That’s because the vaccine is tailored to the currently circulating variants. These data are also encouraging because of what it may mean for the effectiveness of the 2023-2024 COVID-19 vaccine, which is currently under review. Early research data from multiple labs are reassuring and show that existing antibodies work against the new BA.2.86 variant.The current increases in COVID-19 cases and hospitalizations in the United States are not being driven by BA.2.86 and instead are being caused by other predominantly circulating viruses.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |